{"nct_id":"NCT01909934","title":"Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma","status":"COMPLETED","status_verified_date":"2025-08","start_date":"2014-01-23","start_date_type":"ACTUAL","primary_completion_date":"2021-05-04","primary_completion_date_type":"ACTUAL","completion_date":"2024-08-29","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["TAK"]}